Fig. 4From: Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillationRisk of Net Adverse Clinical Events Associated With Non–vitamin K Antagonist Oral Anticoagulant (NOAC) Use Compared With Warfarin Use in Different Subgroups. MI, myocardial infarction; TIA, transient ischemic accident; SSE, systemic embolism; COPD, chronic obstructive pulmonary disease; CI, confidence intervalBack to article page